Optimizing Therapy for Patients with Hormone Receptor (HR)-Positive Localized Breast Cancer — July 31, 2026, Roanoke, VA

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Friday, July 31, 2026

Program Schedule — Eastern Time
11:30 AM – 12:00 PM — Registration and Lunch
12:00 PM – 1:00 PM — Educational Program

Location
Blue Ridge Cancer Care
2013 S Jefferson St
Roanoke, VA 24014

Meeting Room
Roanoke Conference Room 

Angela DeMichele

Faculty

Angela DeMichele

MD, MSCE

Abramson Cancer Center, Philadelphia, Pennsylvania

Mariann T and Robert J MacDonald Professor in Breast Cancer, Director, Clinical/Translational Research, Solid Tumor Oncology, Hematology/Oncology Division, Co-Leader, Breast Cancer Program

Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Co-Director, 2-PREVENT Breast Cancer Translational Center of Excellence, Senior Scholar, Center for Clinical Epidemiology and Biostatistics

Registration

These activities are supported by educational grants from Biotheranostics Inc, A Hologic Company, Exact Sciences Corporation, Lilly, and Novartis.